Abstract
Background: Alcohol consumption induces significant oxidative stress and inflammation, leading to damage in vital organs, particularly the liver and kidneys. Aim: Here, we investigate the potential therapeutic effects of phycocyanin in mitigating alcohol-induced liver and kidney damage and body growth. Methods: Four groups of male rats were included: control, ethanol-exposed (38% w/v, 1 ml/kg), phycocyanin co-treated (50 mg/kg phycocyanin followed by ethanol), and phycocyanin-only treated (50 mg/kg phycocyanin). Results: The results revealed that a 14-day exposure of rats to ethanol resulted in a decrease in body weight, with a significant increase in blood aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT) activity and elevated levels of urea, creatinine, iron, and C-reactive protein compared to the control group. However, co-treatment with phycocyanin significantly attenuated these effects, whereas phycocyanin alone did not induce significant effects. Additionally, ethanol exposure increased oxidative stress, lipid peroxidation and caused histopathological damage in both the liver and kidney. Co-treatment with phycocyanin significantly improved oxidative stress markers and preserved organ structure. Conclusion: These findings suggest that phycocyanin represents a promising natural therapeutic strategy for the prevention and management of alcohol-induced hepatorenal damage, calcium homeostasis alteration and impaired body growth. Major Finding: Phycocyanin exhibits notable antioxidant and anti-inflammatory properties, highlighting potential to improve organ health in cases of alcohol poisoning.

This publication has 50 references indexed in Scilit: